Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever

International Journal of Infectious Diseases

Volumn 12, Issue 2, 2008, Pages 162-165

  Engin, Aynur ^a   Yildirim, Altan ^a   Kunt, Tanfer ^a   Bakir, Mehmet ^a   Dokmetas, Ilyas ^a   Ozdemir, Levent ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cochlea; Crimean Congo hemorrhagic fever; Otoacoustic emission

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; EVOKED OTOACOUSTIC EMISSION; FEMALE; FEVER; HUMAN; INNER EAR DISEASE; MALE;

ADULT; COCHLEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS, SENSORINEURAL; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PROSPECTIVE STUDIES; TURKEY;

EID: 39049163367     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.06.003     Document Type: Article

References (26)

1. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 64 (2004) 145-160
2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6 (2006) 203-214
3. Cleri D.J., Ricketti A.J., Porwancher R.B., Ramos-Bonner L.S., and Vernaleo J.R. Viral hemorrhagic fevers: current status of endemic disease and strategies for control. Infect Dis Clin North Am 20 (2006) 359-393
4. Engdahl B., and Tambs K. Otoacoustic emissions in the general adult population of Nord-Trondelag, Norway: II. Effects of noise, head injuries, and ear infections. Int J Audiol 41 (2002) 78-87
5. Kemp D.T. Otoacoustic emissions, their origin in cochlear function, and use. Br Med Bull 63 (2002) 223-241
6. Lonsbury-Martin B.L., and Martin G.K. Otoacoustic emissions. Curr Opin Otolaryngol Head Neck Surg 11 (2003) 361-366
7. Zhao F., Wada H., Koike T., and Stephens D. The influence of middle ear disorders on otoacoustic emissions. Clin Otolaryngol Allied Sci 25 (2000) 3-8
8. Kemp DT. Understanding and using otoacoustic emissions. Manual based on the OAE Course held at The Institute of Laryngology and Otology, University College London. Hatfield, UK: Otodynamics Ltd; 1997. p. 2.
9. Kemp D.T., Ryan S., and Bray P. A guide to the effective use of otoacoustic emissions. Ear Hear 11 (1990) 93-105
10. Kemp D.T. Exploring cochlear status with otoacoustic emissions. In: Robinette M.S., and Glatthe T.J. (Eds). Otoacoustic emissions, clinical applications. 2nd ed. (2002), Thieme, New York 1-47
11. World Health Organization. Crimean-Congo haemorrhagic fever. Fact sheet No. 208, revised November 2001. Available at: http://www.who.int/mediacentre/factsheets/fs208/en/ (accessed July 2007).
12. Simon M., Falk K.I., Lundkvist A., and Mirazimi A. Exogenous nitric oxide inhibits Crimean-Congo hemorrhagic fever virus. Virus Res 120 (2006) 184-190
13. Ergonul O., Zeller H., Celikbas A., and Dokuzoguz B. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. Int J Infect Dis 11 (2007) 48-51
14. Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M.A., Vahaboglu H., and Turkish CCHF Study Group. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54 (2005) 385-389
15. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerge Infect Dis 10 (2004) 1379-1384
16. Ozkurt Z., Kiki I., Erol S., Erdem F., Yilmaz N., Parlak M., et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52 (2006) 207-215
17. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 37 S-3 (1988) 1-16. http://www.cdc.gov/mmwr/preview/mmwrhtml/00037085.htm Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00037085.htm (accessed July 2007)
18. Swanepoel R., Gill D.E., Shepherd A.J., Leman P.A., Mynhardt J.H., and Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11 Suppl 4 (1989) S794-S800
19. Joubert J.R., King J.B., Rossouw D.J., and Cooper R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J 68 (1985) 722-728
20. Andersson I., Lundkvist A., Haller O., and Mirazimi A. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78 (2006) 216-222
21. Schnittler H.J., and Feldmann H. Viral hemorrhagic fever-a vascular disease?. Thromb Haemost 89 (2003) 967-972
22. Burt F.J., Swanepoel R., Shieh W.J., Smith J.F., Leman P.A., Greer P.W., et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 121 (1997) 839-846
23. Geisbert T.W., and Jahrling P.B. Exotic emerging viral diseases: progress and challenges. Nat Med 10 Suppl 12 (2004) S110-S121
24. Yilmaz I., Yilmazer C., Erkan A.N., Aslan S.G., and Ozluoglu L.N. Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol 26 (2005) 113-117
25. Hoth S., and Weber F.N. The latency of evoked otoacoustic emissions: its relation to hearing loss and auditory evoked potentials. Scand Audiol 30 (2001) 173-183
26. O'Brien A.J. Temperature dependency of the frequency and level of a spontaneous otoacoustic emission during fever. Br J Audiol 28 (1994) 281-290